ERBB2 and breast carcinoma: We recently showed that BRACs suppressed HER2+ breast cancer lung metastasis in a mouse model, and similar antimetastasis effects were seen in HER2+ breast cancer MDA-MB-453 cells treated with 200 μg/mL BRACs [8].